Intrathecal 131I-labeled antitenascin monoclonal antibody 81C6 treatment of patients with leptomeningeal neoplasms or primary brain tumor resection cavities with subarachnoid communication: phase I trial results.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples